Natural Organics
This article was originally published in The Tan Sheet
Executive Summary
Supplement marketer barred from claiming Pedi-Active A.D.D. or any other supplement, food or drug improves children's attention span and scholastic performance and treats or mitigates attention deficit/hyperactivity disorder in children "absent competent and reliable scientific evidence," according to FTC consent agreement released July 31. Melville, N.Y.-based firm also prohibited from using term "A.D.D." as representing treatment for ADHD. Agreement subject to public comment until Aug. 30, after which it could become final. In August 2000, FTC challenged Natural Organics' Pedi-Active claims on ads, brochures, letters and its Web site (1"The Tan Sheet" Aug. 21, p. 7)
You may also be interested in...
Natural Organics ADHD Claims Prohibited Under FTC Complaint
Claims made by Natural Organics for its Pedi-Active A.D.D. dietary supplement improperly suggest the product treats attention deficit hyperactivity disorder and are "unfair or deceptive acts or practices," the Federal Trade Commission determines.
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands